Obesity and CardiovascularDiseases

Current Problems in Cardiology

Volumn 42, Issue 11, 2017, Pages 376-394

  Parto, Parham ^a   Lavie, Carl J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL POLARITY; CELL SIZE; DEPRESSION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FUNCTIONAL ANATOMY; HEART FAILURE; HEART FUNCTION; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RISK FACTOR; VASCULAR ENDOTHELIAL CELL; CARDIOVASCULAR DISEASES; COMPLICATION; HEMODYNAMICS; PATHOPHYSIOLOGY; PROGNOSIS; UNITED STATES;

CARDIOVASCULAR DISEASES; HEMODYNAMICS; HUMANS; OBESITY; PROGNOSIS; RISK FACTORS; UNITED STATES;

EID: 85019076410     PISSN: 01462806     EISSN: 15356280     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2017.04.004     Document Type: Article

References (100)

1. Brinton D, Napheys G: Personal beauty: how to cultivate and preserve it in accordance with the laws of health, 1870. Available at: https://books.google.com/books?hl=en&lr=&id=PDUEAAAAYAAJ&oi=fnd&pg=PA9&dq=Personal+beauty:+how+to+cultivate+and+preserve+it+in+accordance+with+the+laws+of+health&ots=XiKZATnvBz&sig=_pt4TkIuIOXBJmtEoEjsjBRcobU. Cited February 6, 2017.
2. Ortega, F.B., Lavie, C.J., Blair, S.N., Obesity and cardiovascular disease. Circ Res 118 (2016), 1752–1770.
3. Maclennan W. On the treatment of obesity and myxoedema by a new preparation of thyroid “Thyroglandin”. Br Med J, BMJ Group, 1898. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20757948. Cited February 6, 2017;2(1958):79-80.
4. Oliver T. Post-mortem in a case of extreme obesity. J Anat Physiol. Wiley-Blackwell; 1880;14(Pt 3):345-347. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17231332. Cited February 6, 2017.
5. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 2014;384(9945):766-781. Available at: http://linkinghub.elsevier.com/retrieve/pii/S0140673614604608. Cited February 6, 2017.
6. Alpert MA, Lavie CJ, Agrawal H, et al. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management, Transl Res, 2014; Available at: http://www.sciencedirect.com/science/article/pii/S1931524414001340. Cited Dec 27, 2015;164(4):345-356.
7. Lavie, C.J., Alpert, M.A., Arena, R., et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 1 (2013), 93–102.
8. Lavie, C.J., De Schutter, A., Parto, P., et al. Obesity and prevalence of cardiovascular diseases and prognosis—the obesity paradox updated. Prog Cardiovasc Dis 58 (2016), 537–547.
9. Aune, D., Sen, A., Norat, T., et al. Body mass index, abdominal fatness and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation, 115, 2016.
10. Lavie, C.J., Milani, R.V., Ventura, H.O., Obesity and cardiovascular disease. Risk factor, paradox, and impact of weight loss. J Am Coll Cardiol, 53, 2009, 1925–1932.
11. Parto P, Lavie CJ, Ventura HO. Reducing heart failure risks in obese patients. Curr Cardiovasc Risk Rep. Springer, US; Available at: http://link.springer.com/10.1007/s12170-016-0498-1. 2016; cited February 9, 2017;10:15.
12. Lavie, C.J., McAuley, P.A., Church, T.S., et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 63 (2014), 1345–1354.
13. Lavie, C.J., De Schutter, A., Milani, R.V., Body composition and the obesity paradox in coronary heart disease: can heavier really be healthier?. Heart 101 (2015), 1610–1611, 10.1136/heartjnl-2015-307966.
14. Nakamura, K., Fuster, J.J., Walsh, K., Adipokines: a link between obesity and cardiovascular disease. J Cardiol 63 (2014), 250–259.
15. Hirsch, J., Batchelor, B., Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5 (1976), 299–311 http://linkinghub.elsevier.com/retrieve/pii/S0300595X76800230. [cited February 12, 2017].
16. Hausman DB, DiGirolamo M, Bartness TJ, et al. The biology of white adipocyte proliferation. Obes Rev. Blackwell Science Ltd; Available at: http://doi.wiley.com/10.1046/j.1467-789X.2001.00042.x. Cited February 12, 2017;2:239-254.
17. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. American Society for Biochemistry and Molecular Biology; Available at: http://www.ncbi.nlm.nih.gov/pubmed/16150820. Cited February 12, 2017;46:2347-2355.
18. Strissel, K.J., Stancheva, Z., Miyoshi, H., et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56 (2007), 1–8.
19. Xu, H., Barnes, G.T., Yang, Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest, 112, 2003, 1821–1830 http://www.ncbi.nlm.nih.gov/pubmed/14679177;[cited February 12, 2017].
20. Weisberg, S.P., McCann, D., Desai, M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 112, 2003, 1796–1808 http://www.ncbi.nlm.nih.gov/pubmed/14679176 [cited February 12, 2017].
21. Gordon, S., Alternative activation of macrophages. Nat Rev Immunol, 3, 2003, 23–35 http://www.nature.com/doifinder/10.1038/nri978 [cited February 12, 2017].
22. Odegaard, J.I., Chawla, A., Alternative macrophage activation and metabolism. Annu Rev Pathol Mech Dis, 6, 2011, 275–297, 10.1146/annurev-pathol-011110-130138 [cited February 12, 2017].
23. Feingold, K.R., Grunfeld, C., The acute phase response inhibits reverse cholesterol transport. J Lipid Res, 51, 2010, 682–684 http://www.ncbi.nlm.nih.gov/pubmed/20071695 [cited February 21, 2017].
24. Feingold, K.R., Grunfeld, C., Obesity and dyslipidemia. Endotext, 2000 http://www.ncbi.nlm.nih.gov/pubmed/26247088 [cited February 15, 2017].
25. Lara-Castro, C., Fu, Y., Chung, B.H., et al. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 18 (2007), 263–270 http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00041433-200706000-00007 [cited February 21, 2017].
26. Winer, S., Chan, Y., Paltser, G., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med, 15, 2009, 921–929 http://www.nature.com/doifinder/10.1038/nm.2001 [cited February 12, 2017].
27. Winer, D.A., Winer, S., Shen, L., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med, 17, 2011, 610–617 http://www.nature.com/doifinder/10.1038/nm.2353 [cited February 12, 2017].
28. Liu, J., Divoux, A., Sun, J., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med, 15, 2009, 940–945 http://www.nature.com/doifinder/10.1038/nm.1994 [cited February 12, 2017].
29. Talukdar, S., Oh, D.Y., Bandyopadhyay, G., et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med, 18, 2012, 1407–1412 http://www.nature.com/doifinder/10.1038/nm.2885 [cited February 12, 2017].
30. Wu, D., Molofsky, A.B., Liang, H.-E., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332 (2011), 243–247.
31. Nakajima, T., Fujioka, S., Tokunaga, K., et al. Noninvasive study of left ventricular performance in obese patients: Influence of duration of obesity. Circulation 71 (1985), 481–486.
32. Alpert, M.A., Lambert, C.R., Panayiotou, H., et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76 (1995), 1194–1197 http://linkinghub.elsevier.com/retrieve/pii/S0002914999803385 [cited February 12, 2017].
33. Patel, D.A., Lavie, C.J., Milani, R.V., et al. Association of left ventricular geometry with left atrial enlargement in patients with preserved ejection fraction. Congest Heart Fail 18 (2012), 4–8 http://www.ncbi.nlm.nih.gov/pubmed/22151261 [cited January 31, 2016].
34. Baptista de Faria, G., Hauck, A., Krefman, A., et al. Abstract 20159: longitudinal impact of childhood bmi on cardiac structure and function. Circulation, 134(Suppl 1), 2016 : A20159.
35. Lauer, M., Anderson, K., Kannel, W., et al. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. J Am Med Assoc 266 (1991), 231–236 http://jama.jamanetwork.com/article.aspx?articleid=386462 [cited January 31, 2016].
36. Alpert, M., Alexander, J., Cardiac morphology and obesity in man. Alpert, M., Alexander, J., (eds.) The Heart and Lung in Obesity, 1998, Futura Publishing Company, Armonk, NY, 25–44 https://scholar.google.com/scholar?q=Alpert+MA%252C+Alexander+JK.+Cardiac+morphology+and+obesity+in+man.+I1998%253A25-49&btnG=&hl=en&as_sdt=0%252C19#0 [cited January 31, 2016].
37. Alexander, J., Alpert, M., Hemodynamic alterations with obesity in man. In: The Heart and Lung in Obesity, 1998, Futura Publishing Company, Armonk, NY, 45–46 https://scholar.google.com/scholar?q=Alexander+JK+Hemodynamic+alterations+with+obesity+in+man+&btnG=&hl=en&as_sdt=0%252C19#0 [cited January 31, 2016].
38. Wong, C.Y., O'Moore-Sullivan, T., Leano, R., Byrne, N., Beller, E., Marwick, T.H., Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110 (2004), 3081–3087 http://circ.ahajournals.org/content/110/19/3081.short [cited January 31, 2016].
39. Gelber, R.P., Gaziano, J.M., Manson, J.E., Buring, J.E., Sesso, H.D., A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 20 (2007), 370–377.
40. Hsueh, W.A., Buchanan, T.A., Obesity and hypertension. Endocrinol Metab Clin North Am 23 (1994), 405–427 http://www.ncbi.nlm.nih.gov/pubmed/8070430 [cited February 14, 2017].
41. Alpert, M., Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321 (2001), 225–236 http://journals.lww.com/amjmedsci/Abstract/2001/04000/Obesity_Cardiomyopathy___Pathophysiology_and.3.aspx [cited January 31, 2016].
42. Messerli, F.H., Sundgaard-Riise, K., Reisin, E., Dreslinski, G., Dunn, F.G., Frohlich, E., Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 74 (1983), 808–812 http://www.sciencedirect.com/science/article/pii/0002934383910719 [cited February 2, 2016].
43. Messerli, F.H., Sundgaard-Riise, K., Reisin, E.D., et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med, 99, 1983, 757 http://annals.org/article.aspx?articleid=697370 [cited February 2, 2016].
44. Aurigemma, G.P., de Simone, G., Fitzgibbons, T.P., Cardiac remodeling in obesity. Circ Cardiovasc Imaging 6 (2013), 142–152 http://circimaging.ahajournals.org/content/6/1/142.short [cited February 2, 2016].
45. Neeland, I.J., Gupta, S., Ayers, C.R., et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging 6 (2013), 800–807 http://circimaging.ahajournals.org/content/6/5/800.short [cited January 12, 2016].
46. Moore, L.L., Visioni, A.J., Qureshi, M.M., Bradlee, M.L., Ellison, R.C., D'Agostino, R., Weight loss in overweight adults and the long-term risk of hypertension. Arch Intern Med, 165, 2005, 1298, 10.1001/archinte.165.11.1298 [cited February 14, 2017].
47. Parto, P., Lavie, C.J., Swift, D., Sui, X., The role of cardiorespiratory fitness on plasma lipid levels. Expert Rev Cardiovasc Ther 13 (2015), 1177–1183.
48. Park, Y.-M.M., Sui, X., Liu, J., et al. The effect of cardiorespiratory fitness on age-related lipids and lipoproteins. J Am Coll Cardiol 65 (2015), 2091–2100 http://www.ncbi.nlm.nih.gov/pubmed/25975472 [cited February 15, 2017].
49. Cullen, P., Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86 (2000), 943–949.
50. Cui, Y., Blumenthal, R.S., Flaws, J.A., et al. Non–high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med, 161, 2001, 1413, 10.1001/archinte.161.11.1413 [cited February 15, 2017].
51. Anderson, K.M., Castelli, W.P., Levy, D., Cholesterol and mortality. J Am Med Assoc, 257, 1987, 2176, 10.1001/jama.1987.03390160062027 [cited February 15, 2017].
52. Church, T., Lavie, C., Sarzynski, M., Exercise and Lipids. Ballantyne, C., (eds.) Clinical Lipidology: A Companion to Braunwald's Heart Disease, 2nd ed, 2015, Saunders, Philadelphia, PA [cited Feb 21, 2017]. https://books.google.com/books?hl=en&lr=&id=0RXeBAAAQBAJ&oi=fnd&pg=PP1&dq=Ballantyne+C.+Clinical+Lipidology:+A+Companion+to+Braunwald′s+Heart+Disease.+&ots=bjTOg0f67l&sig=qebHn9dfp91gf7tYVLBVx0A33I0.
53. Halverstadt, A., Phares, D.A., Wilund, K.R., Goldberg, A.P., Hagberg, J.M., Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism 56 (2007), 444–450.
54. Grundy, S.M., Cleeman, J.I., Merz, C.N.B., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110 (2004), 227–239.
55. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 285 (2001), 2486–2497 http://www.ncbi.nlm.nih.gov/pubmed/11368702 [cited February 15, 2017].
56. Eckel, R., Jakicic, J., Ard, J., Jesus, J. De, 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. J Am Coll Cardiol 63(25 Part B) (2014), 2960–2984 http://www.onlinejacc.org/content/63/25_part_b/2960.abstract [cited February 21, 2017].
57. Shaw, K.A., Gennat, H.C., O'Rourke, P., Del Mar, C., Exercise for overweight or obesity. Shaw, K.A., (eds.) Coch Datab Syst Rev, 2006, John Wiley & Sons, Ltd, Chichester, UK, 10.1002/14651858.CD003817.pub3 [cited February 21, 2017].
58. Grundy, S.M., Brewer, H.B., Cleeman, J.I., Smith, S.C., Lenfant, C., Definition of metabolic syndrome. Circulation 109 (2004), 433–438.
59. Williams, L., Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation, 106, 2002, 3143 http://circ.ahajournals.org/content/circulationaha/106/25/3143.full.pdf [cited February 24, 2017].
60. Kaur, J., Jaspinder, A comprehensive review on metabolic syndrome. Cardiol Res Pract, 2014, 2014 [Article ID 943162, 21 pages]. http://dx.doi.org/10.1155/2014/943162 http://www.ncbi.nlm.nih.gov/pubmed/24711954 [cited February 24, 2017].
61. Katzmarzyk, P.T., Church, T.S., Janssen, I., Ross, R., Blair, S.N., Metabolic syndrome, obesity, and mortality. Diab Care 28 (2005), 391–397.
62. Isomaa, B., Almgren, P., Tuomi, T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care 24 (2001), 683–689.
63. Calori, G., Lattuada, G., Piemonti, L., et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese italian individuals. Diab Care, 34, 2010.
64. Fan, J., Song, Y., Chen, Y., Hui, R., Zhang, W., Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 168 (2013), 4761–4768.
65. Ortega, F.B., Cadenas-Sánchez, C., Sui, X., Blair, S.N., Lavie, C.J., Role of fitness in the metabolically healthy but obese phenotype: a review and update. Prog Cardiovasc Dis 58 (2015), 76–86 http://linkinghub.elsevier.com/retrieve/pii/S0033062015000304 [cited Mar 12, 2017].
66. Lavie, C.J., De Schutter, A., Milani, R.V., Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol, 11, 2014, 55–62, 10.1038/nrendo.2014.165 [cited Mar 12, 2017].
67. Hatem, S.N., Atrial fibrillation and obesity. J Am Coll Cardiol 66 (2015), 12–13.
68. Abed, H.S., Samuel, C.S., Lau, D.H., et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 10 (2013), 90–100 http://linkinghub.elsevier.com/retrieve/pii/S1547527112009770 [cited February 24, 2017].
69. Wanahita, N., Messerli, F.H., Bangalore, S., Gami, A.S., Somers, V.K., Steinberg, J.S., Atrial fibrillation and obesity—results of a meta-analysis. Am Heart J 155 (2008), 310–315 http://www.sciencedirect.com/science/article/pii/S0002870307007831 [cited January 12, 2016].
70. Wang, T.J., Parise, H., Levy, D., et al. Obesity and the risk of new-onset atrial fibrillation. J Am Med Assoc, 292, 2004, 2471, 10.1001/jama.292.20.2471 [cited February 24, 2017].
71. Rabah, A., Wazni, O., Atrial fibrillation in heart failure: catheter and surgical interventional therapies. Heart Fail Rev 19 (2014), 325–330 http://www.ncbi.nlm.nih.gov/pubmed/24132645 [cited February 14, 2016].
72. Shinbane, J.S., Wood, M.A., Jensen, D.N., Ellenbogen, K.A., Fitzpatrick, A.P., Scheinman, M.M., Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol, 29, 1997, 709–715 http://content.onlinejacc.org/article.aspx?articleid=1121636 [cited February 14, 2016].
73. Clark, D.M., Plumb, V.J., Epstein, A.E., Kay, G.N., Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol, 30, 1997, 1039–1045 http://content.onlinejacc.org/article.aspx?articleid=1124191 [cited February 14, 2016].
74. Wang, T.J., Larson, M.G., Levy, D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 (2003), 2920–2925 http://circ.ahajournals.org/content/107/23/2920.short [cited February 10, 2016].
75. Benjamin, E., Levy, D., Vaziri, S., D'Agostino, R., Belanger, A., Wolf, P., Independent risk factors for atrial fibrillation in a population-based cohort. J Am Med Assoc, 271, 1994, 840 http://jama.jamanetwork.com/article.aspx?articleid=367563 [cited December 4, 2015].
76. Luppino, F.S., de Wit, L.M., Bouvy, P.F., et al. Overweight, obesity, and depression. Arch Gen Psychiatry, 67, 2010, 220, 10.1001/archgenpsychiatry.2010.2 [cited February 25, 2017].
77. Elderon, L., Whooley, M.A., Depression and cardiovascular disease. Prog Cardiovasc Dis 55 (2013), 511–523.
78. Yusuf, S., Hawken, S., Ôunpuu, S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 937–952.
79. Charlson, F.J., Stapelberg, N.J., Baxter, A.J., Whiteford, H.A., Should global burden of disease estimates include depression as a risk factor for coronary heart disease?. BMC Med, 9, 2011, 47 http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-9-47 [cited February 25, 2017].
80. Lavie, C.J., Menezes, A.R., De Schutter, A., Milani, R.V., Blumenthal, J.A., Impact of cardiac rehabilitation and exercise training on psychological risk factors and subsequent prognosis in patients with cardiovascular disease. Can J Cardiol 32 (2016), S365–S373 http://linkinghub.elsevier.com/retrieve/pii/S0828282X16307115 [cited March 12, 2017].
81. Ernstsen, L., Rangul, V., Nauman, J., et al. Protective effect of regular physical activity on depression after myocardial infarction: the Hunt Study. Am J Med 129 (2016), 82–88e1 http://linkinghub.elsevier.com/retrieve/pii/S000293431500786X [cited March 12, 2017].
82. Kachur, S., Menezes, A.R., De Schutter, A., Milani, R.V., Lavie, C.J., Significance of comorbid psychological stress and depression on outcomes after cardiac rehabilitation. Am J Med 129 (2016), 1316–1321, 10.1016/j.amjmed.2016.07.006.
83. Stunkard, A.J., Faith, M.S., Allison, K.C., Depression and obesity. Biol Psychiatry 54 (2003), 330–337.
84. Bornstein, S.R., Schuppenies, A., Wong, M.-L., Licinio, J., Approaching the shared biology of obesity and depression: the stress axis as the locus of gene–environment interactions. Mol Psychiatry 11 (2006), 892–902, 10.1038/sj.mp.4001873 [cited February 25, 2017].
85. Blaine B. Does depression cause obesity? J Health Psychol SAGE Publications, UK; 2008;13:1190–1197. http://dx.doi.org/10.1177/1359105308095977. [cited February 25, 2017].
86. Lavie, C.J., Sharma, A., Alpert, M.A., et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis, 2015 http://www.sciencedirect.com/science/article/pii/S0033062015300293 [cited February 25, 2016].
87. Lavie, C., Osman, A., Milani, R., Mehra, M., Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003), 891–894 https://scholar.google.com/scholar?hl=en&q=vLavie+CJ%252C+Osman+AF%252C+Milani+RV%252C+Mehra+MR.+Body+composition+and+prognosis+in+chronic+sys-+tolic+heart+failure%253A+the+obesity+paradox.+Am+J+Cardiol+2003%253B91%253A891%25E2%2580%25934.&btnG=&as_sdt=1%252C19&as_sdtp=#0 [cited February 1, 2016].
88. Sharma, A., Lavie, C., Borer, J., et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 115 (2015), 1428–1434 http://www.sciencedirect.com/science/article/pii/S0002914915007201 [cited January 31, 2016].
89. Wang, Z.J., Zhou, Y.J., Galper, B.Z., Gao, F., Yeh, R.W., Mauri, L., Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart 101 (2015), 1631–1638 http://www.ncbi.nlm.nih.gov/pubmed/26025084 [cited February 25, 2017].
90. Flegal, K.M., Kit, B.K., Orpana, H., Graubard, B.I., Association of all-cause mortality with overweight and obesity using standard body mass index categories. J Am Med Assoc, 309, 2013, 71, 10.1001/jama.2012.113905 [cited February 25, 2017].
91. Coutinho, T., Goel, K., Corrêa de Sá D., et al. Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of normal weight central obesity. J Am Coll Cardiol 61 (2013), 553–560.
92. Coutinho, T., Goel, K., Corrêa de Sá D., et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 57 (2011), 1877–1886.
93. Wessel, T.R., Arant, C.B., Olson, M.B., et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. J Am Med Assoc, 292, 2004, 1179, 10.1001/jama.292.10.1179 [cited Mar 11, 2017].
94. Artero, E.G., Lee, D., Ruiz, J.R., et al. A prospective study of muscular strength and all-cause mortality in men with hypertension. J Am Coll Cardiol, 57, 2011, 1831–1837 http://content.onlinejacc.org/article.aspx?articleid=1146453 [cited February 13, 2016].
95. Blair, S.N., Kampert, J.B., Kohl, H.W., et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. J Am Med Assoc, 276, 1996, 205, 10.1001/jama.1996.03540030039029 [cited Mar 11, 2017].
96. Lavie, C.J., Cahalin, L.P., Chase, P., et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 88 (2013), 251–258 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=23489451.
97. McAuley, P.A., Artero, E.G., Sui, X., et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 87 (2012), 443–451 http://www.mayoclinicproceedings.org/article/S0025619612002662/fulltext.
98. Uretsky, S., Supariwala, A., Gurram, S., et al. The interaction of exercise ability and body mass index upon long-term outcomes among patients undergoing stress-rest perfusion single-photon emission computed tomography imaging. Am Heart J 166 (2013), 127–133 http://www.sciencedirect.com/science/article/pii/S0002870313002330 [cited February 13, 2016].
99. De Schutter, A., Lavie, C.J., Milani, R.V., The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease-the obesity paradox. Prog Cardiovasc Dis 56 (2014), 401–408, 10.1016/j.pcad.2013.08.003.
100. Archer, E., Thomas, D.M., McDonald, S.M., et al. The Validity of US Nutritional Surveillance: USDA's Loss-Adjusted Food Availability Data Series 1971-2010. Curr Probl Cardiol. 41:11-12 (2016), 268–292.